Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03245931 · ClinicalTrials.gov registry record
Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1
A clinical trial, sponsored by TriHealth.
- Completed
- Registry status
- 8
- Enrollment target
NCT03245931: Completed study, sponsored by TriHealth.
NCT03245931 is a clinical trial that has completed, run by TriHealth. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03245931 has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
The goal of this study is to assess the health literacy level of patients enrolled in the HOPE program, identify any gaps in their knowledge of hepatitis C, analyze the variables that may influence patients' knowledge, and educate patients on Hepatitis C.
Primary Outcome
Through interview, 6 open-ended qualitative questions will be asked of the patients in the HOPE program to assess basic current understanding about Hepatitis C
Interventions
- OTHER Qualitative Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2017-07-20 |
| Est. Completion | 2019-08-26 |
What the finished NCT03245931 record still lists
NCT03245931 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Qualitative Interview is the first listed.
NCT03245931 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03245931 about?
NCT03245931 is a clinical study titled "Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1". The goal of this study is to assess the health literacy level of patients enrolled in the HOPE program, identify any gaps in their knowledge of hepatitis C, analyze the variables that may influence patients' knowledge, and educate patients on Hepatitis C.
What is the current status of trial NCT03245931?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2017-07-20. Estimated completion is 2019-08-26.
What interventions are being tested in trial NCT03245931?
The interventions under investigation include: Qualitative Interview (OTHER).
Who is sponsoring clinical trial NCT03245931?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI